Notably, PD-1 based salvage studies yield posttransplant 2-year progression-free survival rates approaching 90%, marking a significant advancement in the treatment of Hodgkin lymphoma (HL). Studies are beginning to explore nontransplant treatment approaches following front-line treatment failure and may...
Doctors who treat non-Hodgkin lymphoma their treatment includes medical oncologists, hematologist, and radiation oncologists. Your doctor will guide you according to your need for treatment. They will even look for the factors ofwhat kind of lymphoma you have,its stage, your age, how quickly the...
Primary Treatments for Hodgkin and non-Hodgkin's Lymphoma Lymphoma is a cancer type that starts in the lymphocytes and affects the lymphatic system. The cost of lymphoma treatment varies depending on several aspects as its type, disease stages, treatment methods, and doctor’s experience. There ar...
If you are searching for the best immunotherapy in Chennai for yourloved one who has to undergoleukemia cancer treatment in Chennaiorlymphoma cancer treatment in Chennai, then Chennai would be the right place for immunotherapy treatment that can help your loved one to live a long life without th...
predominantly of the male sex. It is a T-cell non-Hodgkin’s lymphoma and it accounts for about 10% of all lymphomas. Polychemotherapy is the first line of treatment for the disease, with a response rate of approximately 90%. Read more about anaplastic lymphoma, symptoms, treatment options...
Hodgkins Lymphoma Hodgkin's Lymphoma is a type of cancer that involves lymphatic system and lymphocytes. Read More Non Hodgkins Lymphoma Non-Hodgkin's Lymphoma is a type of cancer that affects lymphocytes which are part of white blood cell. ...
I saw him while undergoing treatment for Hodgkin's Lymphoma and now, after, for maintenance visits.while in treatment, having chiropractic adjustment helped ease some fatigue and Dr. John was able to recommend a support pillow that I still usrusr. I don't have any long term injuries or sign...
Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive, highly treatment-responsive malignancy that rarely affects the heart. Case A 42-year-old female presented with chest tightness, acute right heart failure, and 2:1 atrial flutter. TTE revealed a large right heart mass with associated RV wa...
Results from the long-term follow-up of frontline therapy for patients with indolent non-Hodgkin's lymphoma (iNHL) show the long-term benefits of chemotherapy in combination with rituximab (Rituxan, Roche/Genentech). However, there is still a question as to which is the best chemotherapy partner...
Second primary diffuse large B cell lymphoma (spDLBCL) is defined as a metachronous tumor occurring after a first primary cancer. To date, while R-CHOP is the standard first-line treatment for de novo DLBCL, no available data show that R-CHOP is the optimal treatment for spDLBCL. This ...